Can-Fite BioPharma Ltd. Gains 26.92%
Thu, Mar 05, 2020 at 05:30 PM
Can-Fite BioPharma Ltd. (CANF:NYSEMKT) shot up at $1.98, representing a gain of 26.9%. On Wed 04 Mar 20, CANF:NYSEMKT hit a New 2-Week Intraday High of $1.79. The stock got featured on our News Catalysts scanner on Thu 05 Mar 20 at 04:24 AM in the 'RECOMMENDATION' category. From Wed 19 Feb 20, the stock recorded 40.00% Up Days and 27.27% Green Days
The share price of the company has been moving sideways in recent weeks.
About Can-Fite BioPharma Ltd. (CANF:NYSEMKT)
Can Fite Biofarma Ltd is a clinical stage biopharmaceutical company. It develops orally bioavailable small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological and ophthalmic diseases.
Top 10 Gainers:
- The Dixie Group, Inc. (DXYN:NASDAQ), 32%
- VelocityShares Daily 2x VIX Short-Term ETN (TVIX:NASDAQ), 31.69%
- Overseas Shipholding Group, Inc. (OSG:NYSE), 28.72%
- Trinity Biotech plc (TRIB:NASDAQ), 28%
- Sundance Energy, Inc. (SNDE:NASDAQ), 27.78%
- Cohen & Company Inc. (COHN:NYSEMKT), 27.75%
- Vipshop Holdings Limited (VIPS:NYSE), 26.98%
- Can-Fite BioPharma Ltd. (CANF:NYSEMKT), 26.92%
- Correvio Pharma Corp. (CORV:NASDAQ), 25.16%
- OPKO Health, Inc. (OPK:NASDAQ), 24.1%